Pretherapeutic morbidity in the prognostic staging of acute leukemia
- 1 March 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 139 (3) , 324-328
- https://doi.org/10.1001/archinte.139.3.324
Abstract
To classify the clinical severity of acute leukemia, the degrees of pretherapeutic infection and hemorrhage were used to construct a taxonony containing 3 stages. The stages are associated with survival gradients that are clinically and statistically distinctive in both acute lymphoblastic leukemia and acute nonlymphoblastic leukemia. Median survival ranged from 64.0 mo. for stage 1 to 10.5 mo. for stage 3 in acute lymphoblastic leukemia, and from 7.1 mo. for stage 1 to 1.2 mo. for stage 3 in acute nonlymphoblastic leukemia. The gradients, which persist when other prognostic factors and secular therapeutic changes are taken into account, are more distinctive than those found with other forms of stratification.This publication has 2 references indexed in Scilit:
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Cytarabine: Therapeutic Trials and Editorial StandardsAnnals of Internal Medicine, 1975